NEWRON PHARMACEUT. EO-20 (NP5) — Working Capital to Net Assets Ratio
NEWRON PHARMACEUT. EO-20 (NP5) has a Working Capital to Net Assets ratio of 108.2% as of December 2025. Working capital of €-12.05 Million (current assets of €38.08 Million minus current liabilities of €50.13 Million) is measured against net assets of €-11.13 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how many days can NEWRON PHARMACEUT. EO-20 fund operations to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
NEWRON PHARMACEUT. EO-20 Working Capital to Net Assets (2021–2025)
This chart shows how NEWRON PHARMACEUT. EO-20's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 108.2%, reflecting working capital of €-12.05 Million against net assets of €-11.13 Million EUR. For the complete balance sheet picture, see NEWRON PHARMACEUT. EO-20 assets under control.
Annual Working Capital to Net Assets for NEWRON PHARMACEUT. EO-20 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for NEWRON PHARMACEUT. EO-20 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check NEWRON PHARMACEUT. EO-20 liquidity resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 108.2% | €-12.05 Million | €-11.13 Million | €38.08 Million | €50.13 Million | ▼ -2470.5 pp |
| 2024 | 2578.7% | €37.60 Million | €1.46 Million | €61.10 Million | €23.51 Million | ▲ +2547.7 pp |
| 2023 | 31.0% | €-9.27 Million | €-29.91 Million | €19.65 Million | €28.93 Million | ▲ +198.2 pp |
| 2022 | -167.2% | €23.45 Million | €-14.03 Million | €28.49 Million | €5.04 Million | ▼ -1318.5 pp |
| 2021 | 1151.4% | €35.77 Million | €3.11 Million | €39.43 Million | €3.65 Million | — |